Literature DB >> 23392000

Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors.

Karen Glanz1, Kathryn Volpicelli, Peter A Kanetsky, Michael E Ming, Lynn M Schuchter, Christopher Jepson, Susan M Domchek, Katrina Armstrong.   

Abstract

BACKGROUND: Little is known about the impact of knowledge of CDKN2A and MC1R genotype on melanoma prevention behaviors like sun avoidance and skin examination in the context of familial melanoma.
METHODS: Seventy-three adults with a family history of melanoma were randomly assigned to be offered individualized CDKN2A and MC1R genotyping results in the context of a genetic counseling session, or the standard practice of not being offered counseling or disclosure of genotyping results. Mixed effects or longitudinal logistic models were used to determine whether the intervention affected change in sun protection habits, skin examinations, and perception and beliefs related to melanoma risk, prevention, and genetic counseling.
RESULTS: All participants in the intervention group who attended genetic counseling sessions chose to receive their test results. From baseline to follow-up, participants in the intervention group reported an increase in the frequency of skin self-examinations compared with a slight decrease in the control group (P = 0.002). Participants in the intervention group reported a smaller decrease in frequency of wearing a shirt with long sleeves than did participants in the control group (P = 0.047). No effect of the intervention was noted for other outcomes.
CONCLUSIONS: Feedback of CDKN2A and MC1R genotype among families without known pathogenic CDKN2A mutations does not seem to decrease sun protection behaviors. IMPACT: While disclosure of CDKN2A and MC1R genotype did not have negative effects on prevention, the benefits of communicating this information remain unclear. The small number of families who tested positive for CDKN2A mutations in this study is a limitation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392000      PMCID: PMC3617083          DOI: 10.1158/1055-9965.EPI-12-1174

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  21 in total

Review 1.  Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians.

Authors:  Katrina Armstrong; Elizabeth Moye; Sankey Williams; Jesse A Berlin; Eileen E Reynolds
Journal:  Ann Intern Med       Date:  2007-04-03       Impact factor: 25.391

2.  No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result.

Authors:  Michel Dorval; Geneviève Gauthier; Elizabeth Maunsell; Michel J Dugas; Isabelle Rouleau; Jocelyne Chiquette; Marie Plante; Rachel Laframboise; Michel Gaudet; Peter J Bridge; Jacques Simard
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-12       Impact factor: 4.254

Review 3.  Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium.

Authors:  R F Kefford; J A Newton Bishop; W Bergman; M A Tucker
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

4.  Family members' perceptions of genetic testing for malignant melanoma--a prospective interview study.

Authors:  Mia Bergenmar; Johan Hansson; Yvonne Brandberg
Journal:  Eur J Oncol Nurs       Date:  2009-04       Impact factor: 2.398

5.  MC1R variants, melanoma and red hair color phenotype: a meta-analysis.

Authors:  Sara Raimondi; Francesco Sera; Sara Gandini; Simona Iodice; Saverio Caini; Patrick Maisonneuve; Maria Concetta Fargnoli
Journal:  Int J Cancer       Date:  2008-06-15       Impact factor: 7.396

Review 6.  Selection criteria for genetic assessment of patients with familial melanoma.

Authors:  Sancy A Leachman; John Carucci; Wendy Kohlmann; Kimberly C Banks; Maryam M Asgari; Wilma Bergman; Giovanna Bianchi-Scarrà; Teresa Brentnall; Brigitte Bressac-de Paillerets; William Bruno; Clara Curiel-Lewandrowski; Femke A de Snoo; Tadeusz Debniak; Marie-France Demierre; David Elder; Alisa M Goldstein; Jane Grant-Kels; Allan C Halpern; Christian Ingvar; Richard F Kefford; Julie Lang; Rona M MacKie; Graham J Mann; Kurt Mueller; Julia Newton-Bishop; Håkan Olsson; Gloria M Petersen; Susana Puig; Darrell Rigel; Susan M Swetter; Margaret A Tucker; Emanuel Yakobson; John A Zitelli; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2009-10       Impact factor: 11.527

7.  Breast cancer screening: evidence for false reassurance?

Authors:  Rianne de Gelder; Elisabeth van As; Madeleine M A Tilanus-Linthorst; Carina C M Bartels; Rob Boer; Gerrit Draisma; Harry J de Koning
Journal:  Int J Cancer       Date:  2008-08-01       Impact factor: 7.396

8.  Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations.

Authors:  Dominique Scherer; Eduardo Nagore; Justo Lorenzo Bermejo; Adina Figl; Rafael Botella-Estrada; Ranjit Kumar Thirumaran; Sabrina Angelini; Kari Hemminki; Dirk Schadendorf; Rajiv Kumar
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

9.  CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families.

Authors:  Lisa G Aspinwall; Samantha L Leaf; Erin R Dola; Wendy Kohlmann; Sancy A Leachman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-06       Impact factor: 4.254

10.  A randomized trial of tailored skin cancer prevention messages for adults: Project SCAPE.

Authors:  Karen Glanz; Elinor R Schoenfeld; Alana Steffen
Journal:  Am J Public Health       Date:  2010-02-18       Impact factor: 9.308

View more
  18 in total

Review 1.  Clinical applications of melanoma genetics.

Authors:  Michele Gabree; Devanshi Patel; Linda Rodgers
Journal:  Curr Treat Options Oncol       Date:  2014-06

2.  Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone.

Authors:  Jennifer M Taber; Lisa G Aspinwall; Tammy K Stump; Wendy Kohlmann; Marjan Champine; Sancy A Leachman
Journal:  J Behav Med       Date:  2015-07-16

3.  Melanoma genetic counseling and test reporting improve screening adherence among unaffected carriers 2 years later.

Authors:  Lisa G Aspinwall; Jennifer M Taber; Samantha L Leaf; Wendy Kohlmann; Sancy A Leachman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-15       Impact factor: 4.254

4.  Discussion of photoprotection, screening, and risk behaviors with children and grandchildren after melanoma genetic testing.

Authors:  Yelena P Wu; Lisa G Aspinwall; Timothy C Michaelis; Tammy Stump; Wendy G Kohlmann; Sancy A Leachman
Journal:  J Community Genet       Date:  2015-06-23

5.  Pediatric Predispositional Genetic Risk Communication: Potential Utility for Prevention and Control of Melanoma Risk as an Exemplar.

Authors:  Yelena P Wu; Darren Mays; Wendy Kohlmann; Kenneth P Tercyak
Journal:  J Genet Couns       Date:  2017-05-25       Impact factor: 2.537

6.  Perceived risk following melanoma genetic testing: a 2-year prospective study distinguishing subjective estimates from recall.

Authors:  Lisa G Aspinwall; Jennifer M Taber; Wendy Kohlmann; Samantha L Leaf; Sancy A Leachman
Journal:  J Genet Couns       Date:  2013-12-10       Impact factor: 2.537

Review 7.  A systematic review of interventions to improve adherence to melanoma preventive behaviors for individuals at elevated risk.

Authors:  Yelena P Wu; Lisa G Aspinwall; Bridgid M Conn; Tammy Stump; Bridget Grahmann; Sancy A Leachman
Journal:  Prev Med       Date:  2016-04-16       Impact factor: 4.018

8.  Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.

Authors:  Lisa G Aspinwall; Tammy K Stump; Jennifer M Taber; Danielle M Drummond; Wendy Kohlmann; Marjan Champine; Sancy A Leachman
Journal:  Transl Behav Med       Date:  2018-01-29       Impact factor: 3.046

9.  Priority of Risk (But Not Perceived Magnitude of Risk) Predicts Improved Sun-Protection Behavior Following Genetic Counseling for Familial Melanoma.

Authors:  Jennifer M Taber; Lisa G Aspinwall; Danielle M Drummond; Tammy K Stump; Wendy Kohlmann; Marjan Champine; Pamela Cassidy; Sancy A Leachman
Journal:  Ann Behav Med       Date:  2021-02-12

10.  Genetic Testing Awareness and Attitudes among Latinos: Exploring Shared Perceptions and Gender-Based Differences.

Authors:  Jada G Hamilton; Elyse Shuk; Guedy Arniella; C Javier González; Geoffrey S Gold; Francesca Gany; Mark E Robson; Jennifer L Hay
Journal:  Public Health Genomics       Date:  2015-11-11       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.